Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-10.47 Insider Own0.10% Shs Outstand142.76M Perf Week1.58%
Market Cap12.05B Forward P/E11.90 EPS next Y7.10 Insider Trans-9.29% Shs Float137.24M Perf Month15.98%
Income-1502.50M PEG- EPS next Q1.62 Inst Own76.80% Short Float4.51% Perf Quarter-3.88%
Sales5.64B P/S2.14 EPS this Y-95.80% Inst Trans3.08% Short Ratio3.74 Perf Half Y-3.74%
Book/sh60.52 P/B1.40 EPS next Y2.09% ROA- Target Price91.79 Perf Year-34.32%
Cash/sh- P/C- EPS next 5Y4.20% ROE- 52W Range71.84 - 139.99 Perf YTD1.44%
Dividend0.64 P/FCF- EPS past 5Y-59.80% ROI0.60% 52W High-39.69% Beta0.74
Dividend %0.76% Quick Ratio1.10 Sales past 5Y0.10% Gross Margin38.20% 52W Low17.53% ATR1.89
Employees13242 Current Ratio1.70 Sales Q/Q0.80% Oper. Margin- RSI (14)63.21 Volatility1.76% 2.42%
OptionableYes Debt/Eq0.68 EPS Q/Q- Profit Margin- Rel Volume0.77 Prev Close84.07
ShortableYes LT Debt/Eq0.65 EarningsFeb 27 AMC Payout- Avg Volume1.65M Price84.43
Recom2.70 SMA206.19% SMA504.67% SMA200-4.65% Volume1,282,000 Change0.43%
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Feb-25-17 12:25AM  [$$] Home Depot Looks Fit, UPS Looks Squeezed at Barrons.com
Feb-22-17 10:23AM  Coverage initiated on Perrigo by Canaccord Genuity
02:33AM  Israeli supermarket chain Shufersal Q4 profit up
Feb-21-17 11:34AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Feb-17-17 08:42AM  Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution PR Newswire
Feb-16-17 08:04AM  Health Care Sector Led the S&P 500s Rally on February 15
Feb-14-17 08:01AM  Perrigo To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 PR Newswire
Feb-13-17 11:46AM  Starboard Value's Jeff Smith Wins Five Perrigo Board Seats at Investopedia
Feb-11-17 01:25AM  [$$] Deckers Outdoor Attracts Activist Investment Firm Marcato at Barrons.com
Feb-10-17 09:28AM  Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?
Feb-08-17 08:50PM  With Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks at TheStreet
Feb-07-17 04:45PM  [$$] US energy stocks retreat as oil price slips at Financial Times
01:39PM  Board Revised as Perrigo Settles With Activist Investor Starboard
09:54AM  Perrigo adds three directors in deal with activist Starboard
09:43AM  Faber Report: Pharma fumbles
09:06AM  [$$] Starboard Reaches Deal to Shake Up Perrigo Board at The Wall Street Journal
09:05AM  Investor Starboard takes several seats on Perrigo board
08:24AM  Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel at MarketWatch
08:18AM  Perrigo adds Starboard CEO to its board
08:12AM  Perrigo reaches deal with Starboard to add five independent directors to its board at MarketWatch
08:09AM  Perrigo Confirms Patent Challenge For Generic Version Of Onexton® Gel PR Newswire
08:02AM  Perrigo Announces Agreement With Starboard PR Newswire
Feb-03-17 05:55AM  Hunting down the years 5 hottest M&A targets at MarketWatch
Feb-02-17 12:36PM  Unusual activity: Bulls pile into PRGO & RH
Jan-25-17 12:50PM  Jerome Dodson Comments on Perrigo
12:36PM  Jerome Dodson's Parnassus Fund 4th Quarter Commentary
10:26AM  Perrigo's (PRGO) Generic Version of Topicort Okayed by FDA
Jan-24-17 08:40AM  Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort® Spray, 0.25% PR Newswire
Jan-23-17 09:01AM  Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open
Jan-18-17 07:47PM  Cramer: The yield on this stock could go down on disappointing Kinder Morgan numbers at CNBC
Jan-17-17 04:05PM  DryShips, Alcobra Sink into Tuesdays 52-Week Low Club
10:00AM  Is Perrigo Company (PRGO) a Great Stock for Value Investors?
Jan-14-17 03:38PM  Perrigo, Ralph Lauren Reach 3-Year Low Prices
Jan-12-17 09:30AM  Biotech and Healthcare Stocks Hit Hard by President Trump's Comments: Latest Reports on Endo International and Perrigo Accesswire
Jan-11-17 05:29PM  Why Perrigo, Novadaq Technologies, and Ethan Allen Interiors Slumped Today at Motley Fool -6.90%
01:59PM  Trump's Comments Slam Drug Stocks at The Wall Street Journal
10:43AM  'The New Valeant'
Jan-10-17 10:53PM  [$$] Valeant Strikes Deals to Shed $2.1 Billion in Assets at The Wall Street Journal
02:06PM  [$$] Valeant Strikes Deals to Shed More Assets at The Wall Street Journal
08:41AM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements
08:27AM  Perrigo Updates Segment Reporting Structure PR Newswire
Jan-07-17 03:03PM  These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017
Jan-05-17 11:34AM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : January 5, 2017
Jan-04-17 08:08AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : January 4, 2017
Jan-01-17 05:48PM  Bargain Hunting: The 10 Worst-Performing Dividend Achievers of 2016
Dec-30-16 04:18PM  5 Worst Performers in the S&P 500 in 2016 at The Wall Street Journal
04:00PM  Make Sure Your Portfolio Is Protected From Volatility
Dec-29-16 08:32AM  Citron Research Tweet Pulled NVIDIA Prices Lower on December 28
Dec-22-16 08:47AM  Perrigo to Present at the J.P. Morgan Global Healthcare Conference PR Newswire
Dec-21-16 11:39AM  Allergan's a Bargain That Could Pop 20%
Dec-20-16 08:58AM  Perrigo Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette® White Ice Mint® Gum PR Newswire
Dec-08-16 12:56PM  ETFs with exposure to Perrigo Co. Plc : December 8, 2016
06:36AM  Perrigo Announces Portfolio Review Developments And Intention To Restructure Branded Consumer Healthcare's Belgium Business PR Newswire
Dec-01-16 10:12AM  Hedge Funds Are Buying Perrigo Company plc Ordinary Shares (PRGO) at Insider Monkey
Nov-29-16 11:05AM  What Do Analysts Have to Say about Mallinckrodt?
Nov-24-16 11:04AM  Patent Litigations to Delay Tevas New Product Launches
Nov-21-16 08:15AM  Post Earnings Coverage as Perrigo Q3 Results Beat Expectations Accesswire
Nov-19-16 01:40AM  [$$] Starboard Value Ponders Perrigo Assets at Barrons.com
Nov-17-16 11:00AM  NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe at Bloomberg
Nov-16-16 02:07AM  Jeffrey Smith's Starboard Value Discloses Major Stake in Perrigo (PRGO) at Investopedia
Nov-15-16 03:44PM  Starboard Value Out Of Darden (DRI), In On Perrigo (PRGO), HP (HPE) in a Big Way at Insider Monkey
10:04AM  Why Did Valeant Revise Its 2016 EPS Guidance?
07:39AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : November 15, 2016
Nov-14-16 02:13PM  ETFs with exposure to Perrigo Co. Plc : November 14, 2016
07:48AM  What did hedge funds trade in Q3?
Nov-11-16 09:47AM  Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
Nov-10-16 04:06PM  Edited Transcript of PRGO earnings conference call or presentation 10-Nov-16 1:30pm GMT +6.71%
09:29AM  Stocks to Watch: Macy's, Hilton and Kohl's at The Wall Street Journal
08:42AM  Perrigo (PRGO) Beats on Q3 Earnings, Revenues; View Intact
08:36AM  [$$] Perrigo Considering Strategic Alternatives for MS Drug at The Wall Street Journal
07:57AM  Early movers: KSS, MET, COP, PRTY, BBY, CAS, SHAK, TWTR, MYL & more at CNBC
07:39AM  Perrigo to review options for Multiple Sclerosis drug Tysabri
07:38AM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q3 2016 Perrigo Company PLC Earnings Release - Before Market Open
05:59AM  Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition
05:56AM  Perrigo reports 3Q loss
02:21AM  Perrigo to review options for multiple sclerosis drug royalties
01:50AM  Perrigo Company plc Reports Third Quarter 2016 Financial Results PR Newswire
01:48AM  Perrigo Company Plc to Review Strategic Alternatives for Tysabri® Royalty Stream PR Newswire
01:45AM  Perrigo Company plc Announces Appointment of Two New Independent Directors to Board PR Newswire
Nov-09-16 07:58AM  Medical Product Nov 10 Earnings Lineup: PRGO, GKOS, VIVO
05:27AM  [$$] Health-Care Stocks Emerge as Winners From Trump Vote at The Wall Street Journal
Nov-08-16 04:10PM  Valeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance
11:47AM  Valeant Shares are Destroyed After Disastrous Q3
08:44AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Nov-07-16 08:27AM  Perrigo (PRGO) Q3 Earnings: What's in Store for the Stock?
Nov-01-16 01:22PM  Jerome Dodson Comments on Perrigo
Oct-27-16 04:48PM  Starboard CEO on Perrigo, Macy's and Retail Investments
04:48PM  Starboard CEO on Perrigo, Macy's and Retail Investments at Bloomberg
03:27PM  Starboard CEO: We've Had a Good Dialogue With Perrigo
03:27PM  Starboard CEO: We've Had a Good Dialogue With Perrigo at Bloomberg
Oct-26-16 08:56AM  Perrigo Company plc to Release Third Quarter Calendar Year 2016 Results on November 10, 2016 PR Newswire
Oct-25-16 10:04AM  Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit
Oct-21-16 11:20AM  7 Blue-Chip Stocks That Are Due for a Turnaround at Kiplinger
Oct-19-16 01:32PM  ETFs with exposure to Perrigo Co. Plc : October 19, 2016
Oct-17-16 01:36PM  Jerome Dodson Goes 2 for 2 in 3rd Quarter
Oct-14-16 02:15PM  Stressed Out: Free Cash Flow Is All That Counts Now for Valeant
Oct-10-16 08:39AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : October 10, 2016
Sep-27-16 06:10PM  Teva Is Well Positioned for New Trends in the US Generic Market
11:04AM  Tevas OTC Business Is Playing out to Be a Key Growth Driver
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wesolowski JohnEVP, President RxDec 15Option Exercise82.6132526,848325Dec 19 04:07 PM
Brown Judy LEVP, Business Ops & CFONov 25Sale89.442,097187,55610,007Nov 28 04:29 PM
Parker Geoffrey M.DirectorNov 21Buy88.752,500221,8752,500Nov 21 03:14 PM
KINGMA TODD WExecutive VP, General CounselNov 21Sale88.6875066,51214,560Nov 23 02:30 PM
Brown Judy LEVP, Business Ops & CFOOct 24Sale90.422,092189,15912,104Oct 26 02:44 PM
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM
KUNKLE GARY K JRDirectorSep 09Option Exercise16.775,81497,50131,501Sep 13 03:01 PM
KUNKLE GARY K JRDirectorSep 09Sale89.955,814522,97425,687Sep 13 03:01 PM
MORRIS HERMAN JRDirectorSep 08Option Exercise16.775,81497,50110,425Sep 09 04:33 PM
MORRIS HERMAN JRDirectorSep 08Sale90.961,07397,5959,352Sep 09 04:33 PM
Brown Judy LEVP, Business Ops & CFOAug 26Sale88.282,095184,94716,292Aug 30 04:38 PM
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM
Brown Judy LEVP, Business Ops & CFOAug 19Option Exercise91.831,692155,37614,121Aug 23 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise91.831,692155,37612,012Aug 23 04:58 PM
Kochan SharonEVP, GM InternationalAug 19Option Exercise91.831,01593,2076,898Aug 23 04:57 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 19Option Exercise91.8333831,0397,678Aug 23 04:57 PM
Farrington ThomasEVP and CIOAug 19Option Exercise91.831,692155,3762,886Aug 23 04:57 PM
HENDRICKSON JOHN TCEOAug 19Option Exercise91.831,692155,3761,692Aug 23 04:56 PM
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM